If you need more lookups,
subscriptions start at $34 USD/month.
Lori Payton Location
New Haven, CT, US
Lori Payton Work
2025 -now Chief Development Officer @
2024 -2025 Principal Consultant and CEO @ Harkness Consulting, LLC
2022 -2024 SVP, Development Strategy and Operations @
2020 -2021 Vice President of Strategy and Business Development @
2019 -2020 SVP, Corporate Strategy, Portfolio and Program Management @
2014 -2019 VP, Global Development Team Leader @
2013 -2014 Owner and Principal Consultant @ Harkness Consulting LLC
2010 -2013 Vice President, Global Medicine Team Leader-ELIQUIS @
2009 -2010 Vice President, Head of Medicine Team Leaders, Primary Care Business Unit @
2004 -2008 Vice President, Head of Portfolio and Project Management, Research and Development @
Lori Payton Education
Wheaton College Massachusetts
B.A. (Biology)
Boston University School of Medicine
Ph.D. (Pharmacology & Experimental Therapuetics)
Lori Payton Skills
Pharmaceutical Industry
Clinical Trials
Drug Development
Clinical Development
Business Intelligence
Organizational Design
Portfolio Management
Competitive Analysis
Operational Excellence
Integration
Drug Discovery
Project Management
Cross-functional Team Leadership
Clinical Research
Lifesciences
Strategy
Commercialization
Program Management
Regulatory Submissions
Pharmaceutics
GLP
Toxicology
Biopharmaceuticals
Oncology
Therapeutic Areas
CRO
R&D
Biotechnology
CRO Management
Life Sciences
Lori Payton Summary
Lori Payton, based in New Haven, CT, US, is currently a Chief Development Officer at Yarrow Bioscience. Lori Payton brings experience from previous roles at Harkness Consulting, LLC, AlloVir, Vista Life Innovations and Sage Therapeutics. Lori Payton holds a B.A. in Biology @ Wheaton College Massachusetts. With a robust skill set that includes Pharmaceutical Industry, Clinical Trials, Drug Development, Clinical Development, Business Intelligence and more. Lori Payton has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Lori Payton?
Find contact details for 700 million professionals.